Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Mugen Ujiie"'
Autor:
Noriko Tomita, Junko Terada-Hirashima, Yukari Uemura, Yosuke Shimizu, Haruka Iwasaki, Rina Yano, Tetsuya Suzuki, Sho Saito, Nobumasa Okumura, Wataru Sugiura, Norio Ohmagari, Mugen Ujiie
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
Mpox is an acute exanthematous disease caused by the monkeypox virus. Since May 2022, it has spread as a community-acquired infection, mainly in Europe and the United States, and urgent measures to prevent this infection were also required in Japan.
Externí odkaz:
https://doaj.org/article/e3e544fff4fa4f90941f5e86a84fb157
Autor:
Rina Yano, Junko Terada-Hirashima, Yukari Uemura, Noriko Tomita, Yosuke Shimizu, Haruka Iwasaki, Nobumasa Okumura, Tetsuya Suzuki, Sho Saito, Mugen Ujiie, Wataru Sugiura, Norio Ohmagari
Publikováno v:
JMIR Research Protocols, Vol 12, p e46955 (2023)
BackgroundIn May 2022, a case of monkeypox (currently known as “mpox”) with no history of overseas travel was reported in the United Kingdom, followed by reports of infections reported in Europe, the United States, and other countries worldwide.
Externí odkaz:
https://doaj.org/article/43f820ed932a4fe18ea22f8080ac0a3f
Publikováno v:
International Journal of Infectious Diseases, Vol 134, Iss , Pp 290-291 (2023)
Externí odkaz:
https://doaj.org/article/8ff6e88d194c4690845b0abdb4165ea8
Autor:
Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Azusa Kamikawa, Yumiko Kito, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari, Wataru Sugiura
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract The humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) upon the coronavirus disease 2019 (COVID-19) vaccination remain to be clarified. Hence, we aimed to investigate the long-term chro
Externí odkaz:
https://doaj.org/article/7b66c86b6e6542ae9c3f1916ebc675d9
Autor:
Kenichiro Takahashi, Masahiro Ishikane, Mugen Ujiie, Noriko Iwamoto, Nobumasa Okumura, Testsuro Sato, Maki Nagashima, Ataru Moriya, Michiyo Suzuki, Masayuki Hojo, Takayuki Kanno, Shinji Saito, Sho Miyamoto, Akira Ainai, Minoru Tobiume, Takeshi Arashiro, Tsuguto Fujimoto, Tomoya Saito, Masaya Yamato, Tadaki Suzuki, Norio Ohmagari
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 5, Pp 998-1001 (2022)
To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29–December 18, 2021. V
Externí odkaz:
https://doaj.org/article/879694f6cdbc407b9b9207531ee755ad
Autor:
Junko Terada-Hirashima, Yuki Takamatsu, Yosuke Shimizu, Yukari Uemura, Junko S. Takeuchi, Noriko Tomita, Kouki Matsuda, Kenji Maeda, Shohei Yamamoto, Ami Fukunaga, Norio Ohmagari, Ayako Mikami, Kengo Sonoda, Mugen Ujiie, Hiroaki Mitsuya, Wataru Sugiura
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Although vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) induce effective immune responses, vaccination with booster doses is necessary because of waning immunity. We conducted an open-label, non-rand
Externí odkaz:
https://doaj.org/article/9e1eb62a8e1847b9bf4013d1581744ff
Autor:
Mugen Ujiie
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Japan’s immunization program resumed proactively recommending the use of the human papillomavirus (HPV) vaccine nationwide in April 2022, after suspending this recommendation in June 2013. The promotion of catch-up vaccinations is an urgent issue t
Externí odkaz:
https://doaj.org/article/166176d83a4e4c04944b7a45ae587d10
Autor:
Makoto Inada, Masahiro Ishikane, Mari Terada, Akihiro Matsunaga, Kenji Maeda, Noriko Iwamoto, Mugen Ujiie, Satoshi Kutsuna, Shinichiro Morioka, Yukihito Ishizaka, Hiroaki Mitsuya, Norio Ohmagari
Publikováno v:
International Journal of Infectious Diseases, Vol 119, Iss , Pp 18-20 (2022)
We present a case of a 58-year-old Japanese man with a history of 2 previous COVID-19 infections, who received 2 doses of mRNA-1273 vaccine. We are not aware of any previous study regarding antibody tendency after 2 infections and 2 vaccinations. We
Externí odkaz:
https://doaj.org/article/b632f2e4cf7a4f58be3154057fba81a7
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1, Pp 1-3 (2022)
After the Japanese Ministry of Health, Labor and Welfare (MHLW) suspended its recommendation for the human papillomavirus (HPV) vaccine in June 2013, the rate of members of the new target population receiving of at least one of three doses of HPV vac
Externí odkaz:
https://doaj.org/article/d7e515a8ef0942128650b3ae53427e65
Autor:
Taketomo Maruki, Masahiro Ishikane, Tetsuya Suzuki, Mugen Ujiie, Harutaka Katano, Norio Ohmagari
Publikováno v:
International Journal of Infectious Diseases, Vol 113, Iss , Pp 55-57 (2021)
We report a case of varicella zoster virus (VZV) meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient. A final diagnosis was made based on identification of VZV via positive polymerase chain reaction of cerebrospinal
Externí odkaz:
https://doaj.org/article/0d871d92c4e242f4b8fad090ba020827